Morgan Stanley Maintains Overweight on Thermo Fisher Scientific, Lowers Price Target to $600
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Tejas Savant has maintained an Overweight rating on Thermo Fisher Scientific (NYSE:TMO) but lowered the price target from $640 to $600.
October 24, 2023 | 12:35 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Thermo Fisher Scientific's price target has been lowered from $640 to $600 by Morgan Stanley, though the Overweight rating is maintained.
The news is directly about Thermo Fisher Scientific. While the Overweight rating is maintained, indicating a positive outlook, the lowering of the price target might cause some short-term uncertainty among investors, potentially impacting the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100